{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:12:39Z","timestamp":1788930759148,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.068","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T09:58:06Z","timestamp":1687946286000},"page":"4888-4898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice"],"prefix":"10.1016","volume":"41","author":[{"given":"Julio","family":"Carrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-4220","authenticated-orcid":false,"given":"Turgut E.","family":"Aktepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Earnest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-9387","authenticated-orcid":false,"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Collett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Torresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6613-8350","authenticated-orcid":false,"given":"Jason M.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron P.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.068_b0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.06.068_b0015","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/jvi.68.6.3794-3802.1994","article-title":"NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies","volume":"68","author":"Amberg","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.068_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s41182-021-00378-0","article-title":"Dual burden of Zika and COVID-19 in India: challenges, opportunities and recommendations","volume":"49","author":"Bardhan","year":"2021","journal-title":"Trop Med Health"},{"key":"10.1016\/j.vaccine.2023.06.068_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005608","article-title":"Zika virus-like particle (VLP) based vaccine","volume":"11","author":"Boigard","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.06.068_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcis.2019.03.022","article-title":"Probing and pressing surfaces of hepatitis C virus-like particles","volume":"545","author":"Collett","year":"2019","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.vaccine.2023.06.068_b0035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01415-20","article-title":"Zika virus-like particles bearing a covalent dimer of envelope protein protect mice from lethal challenge","volume":"95","author":"De Lorenzo","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.068_b0040","article-title":"Brazilian women avoiding pregnancy during Zika epidemic","volume":"43","author":"Diniz","year":"2017","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.vaccine.2023.06.068_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.06.068_b0050","doi-asserted-by":"crossref","unstructured":"Essink B, Chu L, Seger W, Barranco E, Le Cam N, Bennett H et al. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials. The Lancet. Infectious Diseases 2023.","DOI":"10.1016\/S1473-3099(22)00764-2"},{"key":"10.1016\/j.vaccine.2023.06.068_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242367","article-title":"Congenital Zika syndrome: a systematic review","volume":"15","author":"Freitas","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.06.068_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/v10110631","article-title":"Recent Advances in Zika Virus Vaccines","volume":"10","author":"Garg","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.06.068_b0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.06.068_b0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.morpho.2016.01.002","article-title":"Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease","volume":"100","author":"Gherardi","year":"2016","journal-title":"Morphologie"},{"key":"10.1016\/j.vaccine.2023.06.068_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079194","article-title":"Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies","volume":"8","author":"Goff","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.06.068_b0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(16)00320-2","article-title":"Zika virus and microcephaly: why is this situation a PHEIC?","volume":"387","author":"Heymann","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.06.068_b0085","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.0406740101","article-title":"A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2023.06.068_b0090","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.06.068_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00597","article-title":"Modulation of dengue\/Zika virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in zika virus infection","volume":"9","author":"Khandia","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.06.068_b0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.06.068_b0105","doi-asserted-by":"crossref","unstructured":"Mancini MV, Tandavanitj R, Ant TH, Murdochy SM, Gingell DD, Setthapramote C et al. Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model. mSphere 2023;8:e0056422.","DOI":"10.1128\/msphere.00564-22"},{"key":"10.1016\/j.vaccine.2023.06.068_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.06.068_b0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1473-3099(16)00088-8","article-title":"Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis","volume":"16","author":"Paix\u00e3o","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.068_b0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.06.068_b0125","doi-asserted-by":"crossref","first-page":"e01174","DOI":"10.1128\/JVI.01174-18","article-title":"Role of capsid anchor in the morphogenesis of Zika virus","volume":"92","author":"Rana","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.068_b0130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMe1601862","article-title":"Zika Virus and Microcephaly","volume":"374","author":"Rubin","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.06.068_b0135","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/JVI.01691-06","article-title":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles","volume":"81","author":"Schaecher","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.068_b0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.06.068_b0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20111696","article-title":"A germinal center\u2013independent pathway generates unswitched memory B cells early in the primary response","volume":"209","author":"Taylor","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2023.06.068_b0150","doi-asserted-by":"crossref","unstructured":"Thulin NK, Brewer RC, Sherwood R, Bournazos S, Edwards KG, Ramadoss NS et al. Afucosylated maternal anti-dengue IgGs are a biomarker for susceptibility to dengue disease in their infants. bioRxiv 2019;565259.","DOI":"10.1101\/565259"},{"key":"10.1016\/j.vaccine.2023.06.068_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rhm.2016.11.008","article-title":"Inequality, Zika epidemics, and the lack of reproductive rights in Latin America","volume":"24","author":"V\u00e9lez","year":"2016","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.vaccine.2023.06.068_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.06.068_b0165","doi-asserted-by":"crossref","unstructured":"Wang TT, Sewatanon J, Memoli MJ, Wrammert J, Bournazos S, Bhaumik SK, et al. IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity. Science (New York, N.Y.) 2017;355:395-398.","DOI":"10.1126\/science.aai8128"},{"key":"10.1016\/j.vaccine.2023.06.068_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111816","article-title":"Current Advances in Zika Vaccine Development","volume":"10","author":"Wang","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.06.068_b0175","article-title":"Zika, abortion and health emergencies: a review of contemporary debates","volume":"15","author":"Wenham","year":"2019","journal-title":"Global Health"},{"key":"10.1016\/j.vaccine.2023.06.068_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/2043-9113-2-5","article-title":"Monte Carlo simulation of the Spearman-Kaerber TCID50","volume":"2","author":"Wulff","year":"2012","journal-title":"J Clin Bioinforma"},{"issue":"731\u2013742","key":"10.1016\/j.vaccine.2023.06.068_b0185","article-title":"Cross-reactive dengue virus antibodies augment Zika virus infection of human placental macrophages","volume":"24","author":"Zimmerman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2023.06.068_b0190","doi-asserted-by":"crossref","unstructured":"Zorrilla CD, Garc\u00eda Garc\u00eda I, Garc\u00eda Fragoso L, De La Vega A. Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal Considerations. J Infect Diseases 2017;216:S891-s896.","DOI":"10.1093\/infdis\/jix448"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:56Z","timestamp":1759404536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23007570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":37,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23007570"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}